Mood disorder explained

Mood disorder
Synonyms:mental disorder
Field:Psychiatry
Types:Bipolar disorder, cyclothymia, disruptive mood dysregulation disorder, dysthymia, major depressive disorder, premenstrual dysphoric disorder, seasonal affective disorder
Causes:Family history, previous diagnosis of a mood disorder, trauma, stress or major life changes in the case of depression, physical illness or use of certain medications. Depression has been linked to major diseases such as cancer, diabetes, Parkinson's disease and heart disease, Brain structure and function in the case of bipolar disorder.[1]
Medication:Antidepressants, mood stabilizers, antipsychotics

A mood disorder, also known as an affective disorder, is any of a group of conditions of mental and behavioral disorder where a disturbance in the person's mood is the main underlying feature. The classification is in the Diagnostic and Statistical Manual of Mental Disorders (DSM) and International Classification of Diseases (ICD).

Mood disorders fall into seven groups, including; abnormally elevated mood, such as mania or hypomania; depressed mood, of which the best-known and most researched is major depressive disorder (MDD) (alternatively known as clinical depression, unipolar depression, or major depression); and moods which cycle between mania and depression, known as bipolar disorder (BD) (formerly known as manic depression). There are several sub-types of depressive disorders or psychiatric syndromes featuring less severe symptoms such as dysthymic disorder (similar to MDD, but longer lasting and more persistent, though often milder) and cyclothymic disorder (similar to but milder than BD).

In some cases, more than one mood disorder can be present in an individual, like bipolar disorder and depressive disorder. If a mood disorder and schizophrenia are both present in an individual, this is known as schizoaffective disorder. Mood disorders may also be substance induced, or occur in response to a medical condition.

English psychiatrist Henry Maudsley proposed an overarching category of affective disorder.[2] The term was then replaced by mood disorder, as the latter term refers to the underlying or longitudinal emotional state,[3] whereas the former refers to the external expression observed by others.

Classification

Depressive disorders

Individuals with a major depressive episode or major depressive disorder are at increased risk for suicide. Seeking help and treatment from a health professional dramatically reduces the individual's risk for suicide. Studies have demonstrated that asking if a depressed friend or family member has thought of committing suicide is an effective way of identifying those at risk, and it does not "plant" the idea or increase an individual's risk for suicide in any way. Epidemiological studies carried out in Europe suggest that, at this moment, roughly 8.5 percent of the world's population have a depressive disorder. No age group seems to be exempt from depression, and studies have found that depression appears in infants as young as 6 months old who have been separated from their mothers.[4] However, there may be differences between cultures in prevalence of MDD due to cultural influences that "challenge the definition and diagnosis of psychiatric disorders", as seen in a study by Parker et al. that researched MDD in the Chinese.[5] Depressive disorder (also known as depression) is a common mental disorder. It involves a depressed mood or loss of pleasure or interest in activities for long periods of time. Depression is different from regular mood changes and feelings about everyday life. It can affect all aspects of life. Depression can happen to anyone. People who have lived through abuse, severe losses, or other stressful events are more likely to develop depression.[6]

Diagnosticians recognize several subtypes or course specifiers:

Bipolar disorders

It is estimated that roughly 1% of the adult population has bipolar I, a further 1% has bipolar II or cyclothymia, and somewhere between 2% and 5% percent have "sub-threshold" forms of bipolar disorder. Furthermore, the possibility of getting bipolar disorder when one parent is diagnosed with it is 15–30%. Risk, when both parents have it, is 50–75%. Also, while with bipolar siblings the risk is 15–25%, with identical twins it is about 70%.[19]

Substance-induced

A mood disorder can be classified as substance-induced if its etiology can be traced to the direct physiologic effects of a psychoactive drug or other chemical substance, or if the development of the mood disorder occurred contemporaneously with substance intoxication or withdrawal. Also, an individual may have a mood disorder coexisting with a substance abuse disorder. Substance-induced mood disorders can have features of a manic, hypomanic, mixed, or depressive episode. Most substances can induce a variety of mood disorders. For example, stimulants such as amphetamine, methamphetamine, and cocaine can cause manic, hypomanic, mixed, and depressive episodes.[20]

Alcohol-induced

High rates of major depressive disorder occur in heavy drinkers and those with alcoholism. Controversy has previously surrounded whether those who abused alcohol and developed depression were self-medicating their pre-existing depression. Recent research has concluded that, while this may be true in some cases, alcohol misuse directly causes the development of depression in a significant number of heavy drinkers. Participants studied were also assessed during stressful events in their lives and measured on a Feeling Bad Scale. Likewise, they were also assessed on their affiliation with deviant peers, unemployment, and their partner's substance use and criminal offending.[21] [22] [23] High rates of suicide also occur in those who have alcohol-related problems.[24] It is usually possible to differentiate between alcohol-related depression and depression that is not related to alcohol intake by taking a careful history of the patient.[23] [25] [26] Depression and other mental health problems associated with alcohol misuse may be due to distortion of brain chemistry, as they tend to improve on their own after a period of abstinence.[27]

Benzodiazepine-induced

Benzodiazepines, such as alprazolam, clonazepam, lorazepam and diazepam, can cause both depression and mania.

Benzodiazepines are a class of medication commonly used to treat anxiety, panic attacks and insomnia, and are also commonly misused and abused. Those with anxiety, panic and sleep problems commonly have negative emotions and thoughts, depression, suicidal ideations, and often have comorbid depressive disorders. While the anxiolytic and hypnotic effects of benzodiazepines may disappear as tolerance develops, depression and impulsivity with high suicidal risk commonly persist.[28] These symptoms are "often interpreted as an exacerbation or as a natural evolution of previous disorders and the chronic use of sedatives is overlooked". Benzodiazepines do not prevent the development of depression, can exacerbate preexisting depression, can cause depression in those with no history of it, and can lead to suicide attempts.[29] [30] [31] [32] Risk factors for suicide and suicide attempts while using benzodiazepines include high dose prescriptions (even in those not misusing the medications), benzodiazepine intoxication, and underlying depression.[33] [34]

The long-term use of benzodiazepines may have a similar effect on the brain as alcohol, and are also implicated in depression. As with alcohol, the effects of benzodiazepine on neurochemistry, such as decreased levels of serotonin and norepinephrine, are believed to be responsible for the increased depression.[35] [36] [37] [38] [39] Additionally, benzodiazepines can indirectly worsen mood by worsening sleep (i.e., benzodiazepine-induced sleep disorder). Like alcohol, benzodiazepines can put people to sleep but, while asleep, they disrupt sleep architecture: decreasing sleep time, delaying time to REM sleep, and decreasing deep sleep (the most restorative part of sleep for both energy and mood).[40] [41] [42] Just as some antidepressants can cause or worsen anxiety in some patients due to being activating, benzodiazepines can cause or worsen depression due to being a central nervous system depressant—worsening thinking, concentration and problem solving (i.e., benzodiazepine-induced neurocognitive disorder). However, unlike antidepressants, in which the activating effects usually improve with continued treatment, benzodiazepine-induced depression is unlikely to improve until after stopping the medication.

In a long-term follow-up study of patients dependent on benzodiazepines, it was found that 10 people (20%) had taken drug overdoses while on chronic benzodiazepine medication despite only two people ever having had any pre-existing depressive disorder. A year after a gradual withdrawal program, no patients had taken any further overdoses.[31]

Just as with intoxication and chronic use, benzodiazepine withdrawal can also cause depression.[43] [44] [45] While benzodiazepine-induced depressive disorder may be exacerbated immediately after discontinuation of benzodiazepines, evidence suggests that mood significantly improves after the acute withdrawal period to levels better than during use.[28] Depression resulting from withdrawal from benzodiazepines usually subsides after a few months but in some cases may persist for 6–12 months.[46] [47]

Due to another medical condition

"Mood disorder due to a general medical condition" is used to describe manic or depressive episodes which occur secondary to a medical condition.[48] There are many medical conditions that can trigger mood episodes, including neurological disorders (e.g. dementias), hearing loss and associated disorders (e.g. tinnitus or hyperacusis), metabolic disorders (e.g. electrolyte disturbances), gastrointestinal diseases (e.g. cirrhosis), endocrine disease (e.g. thyroid abnormalities), cardiovascular disease (e.g. heart attack), pulmonary disease (e.g. chronic obstructive pulmonary disease), cancer, autoimmune diseases (e.g. multiple sclerosis),[48] and pregnancy.

Not otherwise specified

See also: DSM-IV codes.

Mood disorder not otherwise specified (MD-NOS) is a mood disorder that is impairing but does not fit in with any of the other officially specified diagnoses. In the DSM-IV MD-NOS is described as "any mood disorder that does not meet the criteria for a specific disorder." MD-NOS is not used as a clinical description but as a statistical concept for filing purposes.[49] The diagnosis of MD-NOS does not exist in the DSM-5, however the diagnoses of unspecified depressive disorder and unspecified bipolar disorder are in the DSM-5.[50]

Most cases of MD-NOS represent hybrids between mood and anxiety disorders, such as mixed anxiety-depressive disorder or atypical depression.[49] An example of an instance of MD-NOS is being in minor depression frequently during various intervals, such as once every month or once in three days. There is a risk for MD-NOS not to get noticed, and for that reason not to get treated.[51]

Causes

Meta-analyses show that high scores on the personality domain neuroticism are a strong predictor for the development of mood disorders.[52] A number of authors have also suggested that mood disorders are an evolutionary adaptation (see also evolutionary psychiatry).[53] A low or depressed mood can increase an individual's ability to cope with situations in which the effort to pursue a major goal could result in danger, loss, or wasted effort.[54] In such situations, low motivation may give an advantage by inhibiting certain actions. This theory helps to explain why negative life incidents precede depression in around 80 percent of cases,[55] and why they so often strike people during their peak reproductive years. These characteristics would be difficult to understand if depression were a dysfunction.[54]

A depressed mood is a predictable response to certain types of life occurrences, such as loss of status, divorce, or death of a child or spouse. These are events that signal a loss of reproductive ability or potential, or that did so in humans' ancestral environment. A depressed mood can be seen as an adaptive response, in the sense that it causes an individual to turn away from the earlier (and reproductively unsuccessful) modes of behavior.

A depressed mood is common during illnesses, such as influenza. It has been argued that this is an evolved mechanism that assists the individual in recovering by limiting their physical activity. The occurrence of low-level depression during the winter months, or seasonal affective disorder, may have been adaptive in the past, by limiting physical activity at times when food was scarce. It is argued that humans have retained the instinct to experience low mood during the winter months, even if the availability of food is no longer determined by the weather.

Much of what is known about the genetic influence of clinical depression is based upon research that has been done with identical twins. Identical twins have exactly the same genetic code. It has been found that when one identical twin becomes depressed the other will also develop clinical depression approximately 76% of the time. When identical twins are raised apart from each other, they will both become depressed about 67% of the time. Because both twins become depressed at such a high rate, the implication is that there is a strong genetic influence. If it happened that when one twin becomes clinically depressed the other always develops depression, then clinical depression would likely be entirely genetic.[56]

Bipolar disorder is also considered a mood disorder and it is hypothesized that it might be caused by mitochondrial dysfunction.[57] [58] [59]

Sex differences

Mood disorders, specifically stress-related mood disorders such as anxiety and depression, have been shown to have differing rates of diagnosis based on sex. In the United States, women are two times more likely than men to be diagnosed with a stress-related mood disorder.[60] [61] Underlying these sex differences, studies have shown a dysregulation of stress-responsive neuroendocrine function causing an increase in the likelihood of developing these affective disorders.[62] Overactivation of the hypothalamic-pituitary-adrenal (HPA) axis could provide potential insight into how these sex differences arise. Neuropeptide corticotropin-releasing factor (CRF) is released from the paraventricular nucleus (PVN) of the hypothalamus, stimulating adrenocorticotropic hormone (ACTH) release into the blood stream. From here ACTH triggers the release of glucocorticoids such as cortisol from the adrenal cortex. Cortisol, known as the main stress hormone, creates a negative feedback loop back to the hypothalamus to deactivate the stress response.[63] When a constant stressor is present, the HPA axis remains overactivated and cortisol is constantly produced. This chronic stress is associated with sustained CRF release, resulting in the increased production of anxiety- and depressive-like behaviors and serving as a potential mechanism for differences in prevalence between men and women.[60]

Diagnosis

DSM-5

The DSM-5, released in May 2013, separates the mood disorder chapter from the DSM-IV-TR into two sections: Depressive and related disorders and bipolar and related disorders. Bipolar disorders fall in between depressive disorders and schizophrenia spectrum and related disorders "in recognition of their place as a bridge between the two diagnostic classes in terms of symptomatology, family history and genetics" (Ref. 1, p 123). Bipolar disorders underwent a few changes in the DSM-5, most notably the addition of more specific symptomology related to hypomanic and mixed manic states. Depressive disorders underwent the most changes, the addition of three new disorders: disruptive mood dysregulation disorder, persistent depressive disorder (previously dysthymia), and premenstrual dysphoric disorder (previously in appendix B, the section for disorders needing further research). Disruptive mood dysregulation disorder is meant as a diagnosis for children and adolescents who would normally be diagnosed with bipolar disorder as a way to limit the bipolar diagnosis in this age cohort. Major depressive disorder (MDD) also underwent a notable change, in that the bereavement clause has been removed. Those previously exempt from a diagnosis of MDD due to bereavement are now candidates for the MDD diagnosis.[64]

Treatment

There are different types of treatments available for mood disorders, such as therapy and medications. Behaviour therapy, cognitive behaviour therapy and interpersonal therapy have all shown to be potentially beneficial in depression.[65] Major depressive disorder medications usually include antidepressants; a combination of antidepressants and cognitive behavioral therapy has shown to be more effective than one treatment alone.[66] Bipolar disorder medications can consist of antipsychotics, mood stabilizers, anticonvulsants[67] and/or lithium. Lithium specifically has been proven to reduce suicide and all causes of mortality in people with mood disorders.[68] If mitochondrial dysfunction or mitochondrial diseases are the cause of mood disorders like bipolar disorder,[57] then it has been hypothesized that N-acetyl-cysteine (NAC), acetyl-L-carnitine (ALCAR), S-adenosylmethionine (SAMe), coenzyme Q10 (CoQ10), alpha-lipoic acid (ALA), creatine monohydrate (CM), and melatonin could be potential treatment options.[69] In determining treatment, there are many types of depression scales that are used. One of the depression scales is a self-report scale called Beck Depression Inventory (BDI). Another scale is the Hamilton Depression Rating Scale (HAMD). HAMD is a clinical rating scale in which the patient is rated based on clinician observation.[70] The Center for Epidemiologic Studies Depression Scale (CES-D) is a scale for depression symptoms that applies to the general population. This scale is typically used in research and not for self-reports. The PHQ-9 which stands for Patient-Health Questionnaire-9 questions, is a self-report as well. Finally, the Mood Disorder Questionnaire (MDQ) evaluates bipolar disorder.[71]

Epidemiology

According to a substantial number of epidemiology studies conducted, women are twice as likely to develop certain mood disorders, such as major depression. Although there is an equal number of men and women diagnosed with bipolar II disorder, women have a slightly higher frequency of the disorder.[72]

In 2011, mood disorders were the most common reason for hospitalization among children aged 1–17 years in the United States, with approximately 112,000 stays.[73] Mood disorders were top principal diagnosis for Medicaid super-utilizers in the United States in 2012.[74] Further, a study of 18 states found that mood disorders accounted for the highest number of hospital readmissions among Medicaid patients and the uninsured, with 41,600 Medicaid patients and 12,200 uninsured patients being readmitted within 30 days of their index stay—a readmission rate of 19.8 per 100 admissions and 12.7 per 100 admissions, respectively.[75] In 2012, mood and other behavioral health disorders were the most common diagnoses for Medicaid-covered and uninsured hospital stays in the United States (6.1% of Medicaid stays and 5.2% of uninsured stays).[76]

A study conducted in 1988 to 1994 amongst young American adults involved a selection of demographic and health characteristics. A population-based sample of 8,602 men and women ages 17–39 years participated. Lifetime prevalence were estimated based on six mood measures:

Research

Kay Redfield Jamison and others have explored the possible links between mood disorders – especially bipolar disorder – and creativity. It has been proposed that a "ruminating personality type may contribute to both [mood disorders] and art."[78]

Jane Collingwood notes an Oregon State University study that:

looked at the occupational status of a large group of typical patients and found that 'those with bipolar illness appear to be disproportionately concentrated in the most creative occupational category.' They also found that the likelihood of 'engaging in creative activities on the job' is significantly higher for bipolar than nonbipolar workers.[79]
In Liz Paterek's article "Bipolar Disorder and the Creative Mind" she wrote:
Memory and creativity are related to mania. Clinical studies have shown that those in a manic state will rhyme, find synonyms, and use alliteration more than controls. This mental fluidity could contribute to an increase in creativity. Moreover, mania creates increases in productivity and energy. Those in a manic state are more emotionally sensitive and show less inhibition about attitudes, which could create greater expression. Studies performed at Harvard looked into the amount of original thinking in solving creative tasks. Bipolar individuals, whose disorder was not severe, tended to show greater degrees of creativity.[80]
The relationship between depression and creativity appears to be especially strong among poets.[81] [82]

See also

References

Cited texts

Notes and References

  1. Web site: Mood Disorders . Cleveland Clinic . 2022-06-09.
  2. Lewis . AJ . 1934 . Melancholia: A Historical Review . Journal of Mental Science . 80 . 328 . 1–42 . 10.1192/bjp.80.328.1 . free . live . https://web.archive.org/web/20081215051726/http://bjp.rcpsych.org/cgi/content/citation/80/328/1 . 15 December 2008.
  3. 10.1017/S0033291700004980 . Berrios . GE . 1985 . The Psychopathology of Affectivity: Conceptual and Historical Aspects . Psychological Medicine . 15 . 4. 745–758 . 3909185. 26603488 .
  4. Ayuso-Mateos J.L.. 2001 . Depressive Disorders in Europe: Prevalence figures from the ODIN study . British Journal of Psychiatry . 179 . 4. 308–316 . 10.1192/bjp.179.4.308. 11581110 . etal. free .
  5. Parker . Gordon . Gladstone . Gemma . Chee . Kuan Tsee . June 2001 . Depression in the Planet’s Largest Ethnic Group: The Chinese . American Journal of Psychiatry . en . 158 . 6 . 857–864 . 10.1176/appi.ajp.158.6.857 . free . live . https://web.archive.org/web/20240703190756/https://ajp.psychiatryonline.org/doi/pdf/10.1176/appi.ajp.158.6.857?download=true . Jul 3, 2024 .
  6. Web site: Depressive disorder (depression) . 2024-03-11 . World Health Organization . 31 March 2023 . en.
  7. Gelder & Mayou, Geddes (2005). Psychiatry: Page 170. New York, NY; Oxford University Press Inc.
  8. Web site: Ruta M Nonacs . Postpartum Depression . eMedicine . https://web.archive.org/web/20081013205912/http://www.emedicine.com/med/topic3408.htm . 13 October 2008 . dead.
  9. O'Hara, Michael W. "Postpartum Depression: Causes and consequences." 1995.
  10. 161 . 6 . Pooled analysis of antidepressant levels in lactating mothers, breast milk, and nursing infants . Weissman AM, Levy BT, Hartz AJ, Bentler S, Donohue M, Ellingrod VL, Wisner KL . Am J Psychiatry . 1066–1078 . 2004 . 15169695 . 10.1176/appi.ajp.161.6.1066.
  11. Parry, Barbara L. "Premenstrual and Postpartum Mood Disorders." Volume 9.1. 1996. pp=11–16
  12. Rapkin . AJ . Lewis . EI . Treatment of premenstrual dysphoric disorder . Women's Health . 9 . 6 . 537–56 . November 2013 . 24161307 . 10.2217/whe.13.62. free .
  13. Rosenthal. N.E. 1984. A Description of the syndrome and preliminary findings with Light Therapy. Archives of General Psychiatry. 41. 1. 72–80. 10.1001/archpsyc.1984.01790120076010. 6581756. 2686645.
  14. Lam, Raymond W. . Levitan, Robert D. . 2000 . Pathophysiology of seasonal affective disorder: a review . Journal of Psychiatry and Neuroscience . 25 . 5. 469–480 . 11109298 . 1408021 .
  15. Web site: Millon . T. . 2006 . Personality subtypes . Institute for Advanced Studies in Personology and Psychopathology . 1 November 2010 . dead . https://web.archive.org/web/20131023055645/http://millon.net/taxonomy/summary.htm . 23 October 2013.
  16. Carta, Mauro Giovanni . Altamura, Alberto Carlo . Hardoy, Maria Carolina . 2003. Is recurrent brief depression an expression of mood spectrum disorders in young people? . European Archives of Psychiatry and Clinical Neuroscience . 253 . 3 . 149–53 . 10.1007/s00406-003-0418-5 . 12904979 . etal. 2434/521599 . 26860606 . free.
  17. Rapaport MH, Judd LL, Schettler PJ, Yonkers KA, Thase ME, Kupfer DJ, Frank E, Plewes JM, Tollefson GD, Rush AJ . 2002. A descriptive analysis of minor depression . American Journal of Psychiatry . 159 . 4 . 637–43 . 11925303 . 10.1176/appi.ajp.159.4.637 .
  18. Web site: Melissa Conrad Stöppler . Bipolar Disorder (cont.) . MedicineNet, Inc. . 27 October 2013 . https://web.archive.org/web/20131018063559/http://www.medicinenet.com/bipolar_disorder/page3.htm . 18 October 2013 . live.
  19. Abell. S.. Ey, J. L.. Bipolar Disorder. Clinical Pediatrics. 4 June 2009. 48. 6. 693–694. 19498214 . 10.1177/0009922808316663 . 46493183 .
  20. Web site: Methods for Diagnosing Mood Disorders . faqs.org . 26 November 2013 . live . https://web.archive.org/web/20131203062559/http://www.faqs.org/patents/app/20120321644#b . 3 December 2013.
  21. Fergusson DM, Boden JM, Horwood LJ . Tests of causal links between alcohol abuse or dependence and major depression . Arch. Gen. Psychiatry . 66 . 3 . 260–6 . March 2009 . 10.1001/archgenpsychiatry.2008.543 . 19255375 . free .
  22. Falk DE, Yi HY, Hilton ME . Age of Onset and Temporal Sequencing of Lifetime DSM-IV Alcohol Use Disorders Relative to Comorbid Mood and Anxiety Disorders . Drug Alcohol Depend . 94 . 1–3 . 234–45 . April 2008 . 18215474 . 10.1016/j.drugalcdep.2007.11.022 . 2386955 .
  23. Schuckit MA, Smith TL, Danko GP . A comparison of factors associated with substance-induced versus independent depressions . J Stud Alcohol Drugs . 68 . 6 . 805–12 . November 2007 . 17960298 . 10.15288/jsad.2007.68.805. 17528609 . etal.
  24. Chignon JM, Cortes MJ, Martin P, Chabannes JP . [Attempted suicide and alcohol dependence: results of an epidemiologic survey] . fr . Encephale . 24 . 4 . 347–54 . 1998 . 9809240 .
  25. Schuckit MA, Tipp JE, Bergman M, Reich W, Hesselbrock VM, Smith TL . Comparison of induced and independent major depressive disorders in 2,945 alcoholics . Am J Psychiatry . 154 . 7 . 948–57 . July 1997 . 9210745 . 10.1176/ajp.154.7.948. 10.1.1.461.7953 .
  26. Schuckit MA, Tipp JE, Bucholz KK . The life-time rates of three major mood disorders and four major anxiety disorders in alcoholics and controls . Addiction . 92 . 10 . 1289–304 . October 1997 . 9489046 . 10.1111/j.1360-0443.1997.tb02848.x. etal.
  27. Wetterling T, Junghanns K . December 2000 . Psychopathology of alcoholics during withdrawal and early abstinence. Eur Psychiatry . 15 . 8 . 483–8 . 11175926 . 10.1016/S0924-9338(00)00519-8 . 24094651 .
  28. Long-term use of benzodiazepines: tolerance, dependence and clinical problems in anxiety and mood disorders. Pharmacopsychiatry. July 1996. 0176-3679. 8858711. 127–134. 29. 4. 10.1055/s-2007-979558. S.. Michelini. G. B.. Cassano. F.. Frare. G.. Perugi. 19145509 .
  29. Recent developments in the psychopharmacology of anxiety disorders. Journal of Consulting and Clinical Psychology. August 1996. 0022-006X. 8803355. 660–668. 64. 4. R. B.. Lydiard. O.. Brawman-Mintzer. J. C.. Ballenger. 10.1037/0022-006x.64.4.660.
  30. Evidence-based guidelines for the pharmacological treatment of anxiety disorders: recommendations from the British Association for Psychopharmacology. Journal of Psychopharmacology. November 2005. 0269-8811. 16272179. 567–596. 19. 6. 10.1177/0269881105059253. David S.. Baldwin. Ian M.. Anderson. David J.. Nutt. Borwin. Bandelow. A.. Bond. Jonathan R. T.. Davidson. J. A.. den Boer. Naomi A.. Fineberg. Martin. Knapp. 15685770. 5 July 2019. 30 April 2019. https://web.archive.org/web/20190430005347/http://tud.qucosa.de/api/qucosa%3A26469/attachment/ATT-0/. dead.
  31. Benzodiazepine withdrawal: outcome in 50 patients. British Journal of Addiction. June 1987. 0952-0481. 2886145. 665–671. 82. 6. C. H.. Ashton. 10.1111/j.1360-0443.1987.tb01529.x .
  32. Treatment of recent trauma survivors with benzodiazepines: a prospective study. The Journal of Clinical Psychiatry. September 1996. 0160-6689. 9746445. 390–394. 57. 9. E. . Gelpin. O.. Bonne. T.. Peri. D.. Brandes. A. Y.. Shalev.
  33. Prevalence and trends of benzodiazepine use among Veterans Affairs patients with posttraumatic stress disorder, 2003–2010. Drug and Alcohol Dependence. July 2012. 1879-0046. 154–161 . 124. 1–2. Eric J. . Hawkins. Carol A.. Malte. Zac E.. Imel . Andrew J.. Saxon. Daniel R.. Kivlahan. 10.1016/j.drugalcdep.2012.01.003 . 22305658 .
  34. Comorbid Anxiety as a Suicide Risk Factor Among Depressed Veterans. Depression and Anxiety. January 2009. 1091-4269. 2935592. 19544314 . 752–757. 26. 8. 10.1002/da.20583. Paul N. . Pfeiffer. Dara. Ganoczy. Mark. Ilgen. Kara. Zivin. Marcia . Valenstein.
  35. Web site: Professor Heather Ashton . 2002 . Benzodiazepines: How They Work and How to Withdraw.
  36. Lydiard RB, Laraia MT, Ballenger JC, Howell EF . Emergence of depressive symptoms in patients receiving alprazolam for panic disorder . Am J Psychiatry . 144 . 5 . 664–665 . May 1987 . 3578580 . 10.1176/ajp.144.5.664.
  37. Nathan RG, Robinson D, Cherek DR, Davison S, Sebastian S, Hack M . January 1985 . Long-term benzodiazepine use and depression . Am J Psychiatry . 142 . 1 . 144–145 . 2857068 . 10.1176/ajp.142.1.144-b . 21 March 2009 . 16 May 2008 . https://web.archive.org/web/20080516053102/http://ajp.psychiatryonline.org/cgi/reprint/142/1/144a . dead .
  38. Addiction: Part I. Benzodiazepines—side effects, abuse risk and alternatives. American Family Physician. April 2000. 0002-838X. 10779253. 2121–2128. 61. 7. L. P.. Longo. B.. Johnson.
  39. Book: Psychiatry, third edition . Tasman A, Kay J, Lieberman JA . John Wiley & Sons. 2008. Chichester, England. 2603–2615.
  40. The diagnosis and management of benzodiazepine dependence. Current Opinion in Psychiatry . May 2005. 0951-7367. 16639148. 249–255. 18. 3. 10.1097/01.yco.0000165594.60434.84. Heather. Ashton. 1709063 .
  41. Long-term outcome after discontinuation of benzodiazepines for insomnia: a survival analysis of relapse. Behaviour Research and Therapy. January 2005. 0005-7967. 15531349. 1–14. 43. 1. 10.1016/j.brat.2003.12.002. Charles M.. Morin. Lynda. Bélanger. Célyne. Bastien. Annie. Vallières.
  42. Chronic benzodiazepine usage and withdrawal in insomnia patients. Journal of Psychiatric Research. June 2004. 0022-3956. 15003439. 327–334. 38. 3. 10.1016/j.jpsychires.2003.10.003. Dalva. Poyares. Christian. Guilleminault. Maurice M.. Ohayon. Sergio. Tufik.
  43. Fyer AJ, Liebowitz MR, Gorman JM, Campeas R, Levin A, Davies SO, Goetz D, Klein DF . March 1987 . Discontinuation of Alprazolam Treatment in Panic Patients . Am J Psychiatry . 144 . 3 . 303–8 . 3826428. 10 December 2008 . 10.1176/ajp.144.3.303.
  44. Psychosomatics . March–April 1997 . 38 . 2 . 160–1 . Protracted benzodiazepine withdrawal syndrome mimicking psychotic depression . Modell JG . 9063050 . https://wayback.archive-it.org/all/20080625161217/http://psy.psychiatryonline.org/cgi/reprint/38/2/160.pdf . dead . 25 June 2008 . 10.1016/S0033-3182(97)71493-2 . 21 March 2009 .
  45. Lader M . Anxiety or depression during withdrawal of hypnotic treatments . J Psychosom Res . 38 . Suppl 1 . 113–23; discussion 118–23 . 1994 . 7799243 . 10.1016/0022-3999(94)90142-2.
  46. Psychiatric Annals . March 1995 . 25 . 3 . 174–179 . Protracted Withdrawal From Benzodiazepines: The Post-Withdrawal Syndrome . Ashton CH . 10.3928/0048-5713-19950301-11.
  47. Web site: Professor Heather Ashton. 2004. Protracted Withdrawal Symptoms From Benzodiazepines . Comprehensive Handbook of Drug & Alcohol Addiction.
  48. Hales E and Yudofsky JA, eds, The American Psychiatric Press Textbook of Psychiatry, Washington, DC: American Psychiatric Publishing, Inc., 2003
  49. Web site: Akiskal . Hagop S. . Mood Disorders: Clinical Features . 2 November 2004 . Kaplan & Sadock's Comprehensive Textbook of Psychiatry . 21 March 2013 . live . https://web.archive.org/web/20150610220404/http://www.brown.edu/Courses/BI_278/Other/Teaching%20examples/Brain%20and%20Behavior/articles/mood.pdf . 10 June 2015.
  50. Book: Force., American Psychiatric Association. American Psychiatric Association. DSM-5 Task. Diagnostic and statistical manual of mental disorders : DSM-5.. 2017. American Psychiatric Association. 978-0-89042-554-1. 1042815534.
  51. Williams Daniel T. . Hirsch Scott . Coffey Barbara . 2007 . Mood and Anxiety Symptoms in An Adolescent with Pervasive Developmental Disorder Not Otherwise Specified and Moderate Mental Retardation. Journal of Child and Adolescent Psychopharmacology . 17 . 5. 721–726 . 10.1089/cap.2007.17503 . 17979592 .
  52. Jeronimus BF, Kotov R, Riese H, Ormel J . 2016 . Neuroticism's prospective association with mental disorders: A meta-analysis on 59 longitudinal/prospective studies with 443 313 participants . Psychological Medicine . 10.1017/S0033291716001653 . 27523506 . 46 . 14 . 2883–2906 . 23548727 .
  53. Allen . N. . Badcock . P. . 10.1016/j.pnpbp.2006.01.007 . Darwinian models of depression: A review of evolutionary accounts of mood and mood disorders . Progress in Neuro-Psychopharmacology and Biological Psychiatry . 30 . 5 . 815–826 . 2006 . 16647176. 5954047 .
  54. Nesse R . Is Depression an Adaptation? . Arch. Gen. Psychiatry . 57 . 1 . 14–20 . 2000 . 10632228 . live . 10.1001/archpsyc.57.1.14 . 10.1.1.318.2659 . https://web.archive.org/web/20111125222523/http://www-personal.umich.edu/%7Enesse/Articles/IsDepAdapt-ArchGenPsychiat-2000.pdf . 25 November 2011.
  55. Kessler. R. The Effects of Stressful Life Events on Depression. Annual Review of Psychology. 1997. 48. 191–214. 9046559 . 10.1146/annurev.psych.48.1.191.
  56. Web site: What are the main causes of depression or depressive disorders (psychology)? . Eris Consulting . 10 June 2015 . dead . https://web.archive.org/web/20150610110247/http://www.erissolver.com/sq/What-are-the-main-causes-of-depression-or-depressive-disorders-(psychology) . 10 June 2015.
  57. Pieczenik, Steve R. . Neustadt, John . Mitochondrial dysfunction and molecular pathways of disease . Experimental and Molecular Pathology . 83 . 1 . 84–92 . 2007 . 17239370 . 10.1016/j.yexmp.2006.09.008.
  58. Web site: Mitochondrial dysfunction and bipolar disorder . 29 September 2017 . 1 October 2017 . live . https://web.archive.org/web/20171001165713/https://bipolarnutrition.wordpress.com/2017/09/29/mitochondrial-dysfunction-and-bipolar-disorder/ . 1 October 2017.
  59. Scainiab, Giselli, Rezinc, Gislaine, Carvalhod, Andre, Streckb, Emilio L, Berkef, Michael, Quevedo, João . Mitochondrial dysfunction in bipolar disorder: Evidence, pathophysiology and translational implications . Neurosci Biobehav Rev . 68 . 694–713 . 2016 . 10.1016/j.neubiorev.2016.06.040 . 27377693. 207092957 .
  60. Rosinger . Zachary . Sex-dependent effects of chronic variable stress on discrete corticotropin-releasing factor receptor 1 cell populations . Physiology & Behavior . 2020. 219 . 112847 . 10.1016/j.physbeh.2020.112847 . 32081812 . 7540729 .
  61. Blume . Shannon . Disruptive effects of repeated stress on basolateral amygdala neurons and fear behavior across the estrous cycle in rats . Scientific Reports . 23 August 2019 . 9 . 1 . 12292 . 10.1038/s41598-019-48683-3. 31444385 . 6707149 . 2019NatSR...912292B . free .
  62. Weiser . Michael . Androgen regulation of corticotropin-releasing hormone receptor 2 (CRHR2) mRNA expression and receptor binding in the rat brain . Experimental Neurology . 26 July 2008 . 214 . 1 . 62–68 . 10.1016/j.expneurol.2008.07.013 . 18706413. 2891365 .
  63. Ramot . Assaf . Hypothalamic CRFR1 is essential for HPA axis regulation following chronic stress . Nature Neuroscience . March 2017 . 20 . 3 . 385–388 . 10.1038/nn.4491 . 28135239. 5017743 .
  64. Parker. George. DSM-5 and Psychotic and Mood Disorders. Journal of the American Academy of Psychiatry and the Law. 2014. 42. 2 . 182–190. 24986345.
  65. Weston. Drew. Morrison. Kate. A multidimensional meta-analysis of treatments for depression, panic, and generalized anxiety disorder: An empirical examination of the status of empirically supported therapies. Journal of Consulting and Clinical Psychology. 2001 . 69. 6. 875–899. 10.1037/0022-006X.69.6.875 . 11777114 . 10.1.1.200.7241.
  66. Karyotaki. E.. Smit. Y.. Holdt Henningsen. K.. Huibers. M.J.H. . Robays. J.. de Beurs. D.. Cuijpers. P.. 2016 . Combining pharmacotherapy and psychotherapy or monotherapy for major depression? A meta-analysis on the long-term effects. Journal of Affective Disorders. 194 . 144–152. 10.1016/j.jad.2016.01.036. 26826534 . 0165-0327. 1871.1/adac41b1-0b2a-449f-a4df-b8e9baebddde . free.
  67. Keck. Paul E. Jr.. McElroy . Susan L. . Susan McElroy . Strakowski. Stephen M.. Anticonvulsants and antipsychotics in the treatment of bipolar disorder. The Journal of Clinical Psychiatry . 1998. 59. Suppl 6 . 74–82. 9674940.
  68. Cipriani. A. 2013. Lithium in the prevention of suicide in mood disorders: updated systematic review and meta-analysis. BMJ. 346. 1. 23814104 . 10.1136/bmj.f3646. free.
  69. Nierenberg, Andrew A, Kansky, Christine, Brennan, Brian P, Shelton, Richard C, Perlis, Roy, Iosifescu, Dan V . Mitochondrial modulators for bipolar disorder: A pathophysiologically informed paradigm for new drug development. Australian & New Zealand Journal of Psychiatry . 47 . 1 . 26–42 . 2012 . 10.1177/0004867412449303. 22711881 . 22983555 .
  70. Kim. Eun Young. Hwang. Samuel Suk-Hyun . Lee. Nam Young. Kim. Se Hyun. Lee. Hyun Jeong. Kim. Yong Sik . Ahn . Yong Min . June 2013. Intelligence, temperament, and personality are related to over- or under-reporting of affective symptoms by patients with euthymic mood disorder. Journal of Affective Disorders . 148. 2–3 . 235–242. 10.1016/j.jad.2012.11.065. 23270973 . 0165-0327.
  71. Choi. Seung W.. Schalet. Benjamin. Cook. Karon F.. Cella. David . 2014. Establishing a common metric for depressive symptoms: Linking the BDI-II, CES-D, and PHQ-9 to PROMIS Depression.. Psychological Assessment. 26. 2. 513–527. 10.1037/a0035768 . 24548149. 5515387. 1939-134X.
  72. Bauer, M., Pfenning, A. (2005). Epidemiology of Bipolar Disorders. Epilepsia, 46(s4), 8–13.
  73. Pfuntner A, Wier LM, Stocks C . Most Frequent Conditions in U.S. Hospitals, 2011 . HCUP Statistical Brief . 162 . September 2013 . Agency for Healthcare Research and Quality . Rockville, MD. . 9 February 2016 . live . https://web.archive.org/web/20160304032807/http://www.hcup-us.ahrq.gov/reports/statbriefs/sb162.jsp . 4 March 2016.
  74. Jiang HJ, Barrett ML, Sheng M . Characteristics of Hospital Stays for Nonelderly Medicaid Super-Utilizers, 2012 . HCUP Statistical Brief . 184 . Agency for Healthcare Research and Quality . Rockville, MD . November 2014 . 25590126 . 6 April 2015 . dead . https://web.archive.org/web/20150411224657/https://www.hcup-us.ahrq.gov/reports/statbriefs/sb184-Hospital-Stays-Medicaid-Super-Utilizers-2012.jsp . 11 April 2015.
  75. Hines AL, Barrett ML, Jiang HJ, Steiner CA . Conditions With the Largest Number of Adult Hospital Readmissions by Payer, 2011 . HCUP Statistical Brief . 172 . Agency for Healthcare Research and Quality . Rockville, MD . April 2014 . 24901179 . live . https://web.archive.org/web/20160304052719/http://hcup-us.ahrq.gov/reports/statbriefs/sb172-Conditions-Readmissions-Payer.jsp . 4 March 2016.
  76. Lopez-Gonzalez L, Pickens GT, Washington R, Weiss AJ . Characteristics of Medicaid and Uninsured Hospitalizations, 2012 . HCUP Statistical Brief . 183 . Agency for Healthcare Research and Quality . Rockville, MD . October 2014 . 25535644 . live . https://web.archive.org/web/20141129104408/https://www.hcup-us.ahrq.gov/reports/statbriefs/sb182-Medicaid-Uninsured-Hospitalizations-2012.jsp . 29 November 2014.
  77. Nesse, Randolphe M.; Williams, George C. (1994). Why We Get Sick: The New Science of Darwinian Medicine. Vintage Books.
  78. News: Experts ponder link between creativity, mood disorders . 13 May 2010 . CNN . 2 April 2009 . https://web.archive.org/web/20100327185226/http://www.cnn.com/2008/HEALTH/conditions/10/07/creativity.depression/index.html . 27 March 2010 . live.
  79. Web site: Collingwood . Jane . 2010 . The Link Between Bipolar Disorder and Creativity . Psych Central . 19 November 2011 . dead . https://web.archive.org/web/20111022082308/http://psychcentral.com/lib/2010/the-link-between-bipolar-disorder-and-creativity/ . 22 October 2011.
  80. Web site: Paterek . Liz . Bipolar Disorder and the Creative Mind . Serendip . 2006 .
  81. Kaufman . JC . The Sylvia Plath effect: Mental illness in eminent creative writers . Journal of Creative Behavior . 35 . 1 . 37–50 . 2001 . 0022-0175 . 10.1002/j.2162-6057.2001.tb01220.x . dead . https://web.archive.org/web/20120302025608/http://creativeeducation.metapress.com/content/p1t4563378366t55/fulltext.pdf . 2 March 2012.
  82. Bailey . DS . Considering Creativity: The 'Sylvia Plath' effect . Monitor on Psychology . 34 . 10 . 42 . 2003 . live . https://web.archive.org/web/20081020181540/http://www.apa.org/monitor/nov03/plath.html . 20 October 2008.

This article is licensed under the GNU Free Documentation License. It uses material from the Wikipedia article "Mood disorder".

Except where otherwise indicated, Everything.Explained.Today is © Copyright 2009-2024, A B Cryer, All Rights Reserved. Cookie policy.